Shenzhen Edge Medical Co., Ltd. released its Monthly Return for Equity Issuer for the period ended 31 May 2026, confirming a stable capital structure and adherence to Hong Kong Stock Exchange public-float requirements.

Registered Share Capital • Total registered share capital remained unchanged at RMB 391.88 million, comprising 327.76 million H-shares and 64.12 million unlisted domestic shares, each with a par value of RMB 1.

Issued Shares and Treasury Position • No new shares were issued, repurchased, or cancelled during May. • Outstanding H-share count stood at 327.76 million, with zero treasury shares recorded at both the start and end of the month. • Unlisted domestic shares were steady at 64.12 million.

Public-Float Status • The company confirmed full compliance with the Main Board Rule 13.32D(1) minimum public-float threshold of 15 percent as of 31 May 2026.

Capital Instruments and Corporate Actions • No movements were reported in share options, warrants, convertibles, or other equity-linked instruments. • No Hong Kong Depositary Receipts are outstanding.

Filing Details • The return was submitted on 4 June 2026 by Joint Company Secretary Wu Mengyuan, affirming that all regulatory and listing-rule obligations related to the period were met.